S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ELDN Eledon Pharmaceuticals Inc

2.44

0.00 (0.00%)

Pre Market

Last Updated: 18:16:51

Delayed by 15 minutes

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

null

Eledon Pharmaceuticals (NASDAQ:ELDN)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Eledon Pharmaceuticals Charts.

Eledon Pharmaceuticals (NASDAQ:ELDN)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Eledon Pharmaceuticals Charts.

Eledon Pharmaceuticals Inc News

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
Friday 29 March 2024 (1 month ago) • GlobeNewswire Inc.

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
Tuesday 26 March 2024 (1 month ago) • GlobeNewswire Inc.

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
Friday 22 March 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 14 February 2024 (3 months ago) • GlobeNewswire Inc.

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
Friday 5 January 2024 (4 months ago) • GlobeNewswire Inc.

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 5 December 2023 (5 months ago) • GlobeNewswire Inc.

Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
Thursday 30 November 2023 (5 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 10 November 2023 (6 months ago) • Edgar (US Regulatory)

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
Friday 10 November 2023 (6 months ago) • GlobeNewswire Inc.

Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference
Thursday 9 November 2023 (6 months ago) • GlobeNewswire Inc.

More Eledon Pharmaceuticals Inc News Articles

JP Morgan Chase

Australia And New Zealan...

Sterling vs AUD

Verizon Communications

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions